Private Equity Buyout and Restructuring of Physician Management and Oncology Services Company

We served as lead regulatory counsel to a private equity investment firm related to the financing of a complex buyout and restructuring of a company providing physician management and radiation oncology management services and cancer centers.

You Also May Be Interested In:

  • Represented TVV Capital portfolio company Big 3 Precision Products, Inc., a maker of turnkey packaging solutions, in its sale to The Eastern Company (Nasdaq: EML), a publicly traded diversified manufacturer, for $81.7 million

    We represented TVV Capital portfolio company Big 3 Precision Products, Inc., a maker of turnkey packaging solutions, in its sale...
    Client Type: Private Company
  • We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

     

    We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
    Client Type: Public Company
  • We represented Verdi Oncology, Inc. in its acquisition of NexGen Oncology. With the acquisition of NexGen, Verdi has launched Verdi...
    Client Type: Private Company